Dynavax Technologies Corp (DVAX)
12.36
+0.19
(+1.56%)
USD |
NASDAQ |
Nov 21, 16:00
12.38
+0.02
(+0.12%)
Pre-Market: 20:00
Dynavax Technologies Profit Margin (Quarterly): 21.82% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 21.82% |
| June 30, 2024 | 15.43% |
| March 31, 2024 | -17.17% |
| December 31, 2023 | 0.39% |
| September 30, 2023 | 20.56% |
| June 30, 2023 | 5.69% |
| March 31, 2023 | -51.85% |
| December 31, 2022 | 36.71% |
| September 30, 2022 | 38.04% |
| June 30, 2022 | 50.20% |
| March 31, 2022 | 28.83% |
| December 31, 2021 | 51.15% |
| September 30, 2021 | -26.26% |
| June 30, 2021 | 8.48% |
| March 31, 2021 | 1.07% |
| December 31, 2020 | -79.12% |
| September 30, 2020 | 32.81% |
| June 30, 2020 | -1.93K% |
| March 31, 2020 | -115.3% |
| December 31, 2019 | -347.7% |
| September 30, 2019 | -316.4% |
| June 30, 2019 | -514.6% |
| March 31, 2019 | -687.2% |
| December 31, 2018 | -751.6% |
| September 30, 2018 | -2.77K% |
| Date | Value |
|---|---|
| June 30, 2018 | -3.15K% |
| March 31, 2018 | -23.61K% |
| December 31, 2017 | -130.6K% |
| September 30, 2017 | -41.75K% |
| June 30, 2017 | -19.35K% |
| March 31, 2017 | -17.09K% |
| December 31, 2016 | -298.1% |
| September 30, 2016 | -21.42K% |
| June 30, 2016 | -1.10K% |
| March 31, 2016 | -2.87K% |
| December 31, 2015 | -3.92K% |
| September 30, 2015 | -2.54K% |
| June 30, 2015 | -1.52K% |
| March 31, 2015 | -4.18K% |
| December 31, 2014 | -978.7% |
| September 30, 2014 | -1.35K% |
| June 30, 2014 | -812.9% |
| March 31, 2014 | -395.7% |
| December 31, 2013 | |
| September 30, 2013 | -535.5% |
| June 30, 2013 | -506.0% |
| March 31, 2013 | -998.8% |
| December 31, 2012 | |
| September 30, 2012 | -619.0% |
| June 30, 2012 | -563.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.93K%
Minimum
Jun 2020
51.15%
Maximum
Dec 2021
-113.0%
Average
7.09%
Median
Profit Margin (Quarterly) Benchmarks
| Biogen Inc | 15.76% |
| Repligen Corp | -0.42% |
| West Pharmaceutical Services Inc | 18.21% |
| Janux Therapeutics Inc | -6.39K% |
| XOMA Royalty Corp | -2.35K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.23% |
| Return on Assets | 2.03% |
| Return on Invested Capital | 2.39% |
| Gross Profit Margin (Quarterly) | 83.77% |
| Operating Margin (Quarterly) | 12.50% |
| Return on Net Operating Assets | 10.81% |